Gene Mack Gain Therapeutics, Inc. (GANX) insider trading activity
Gene Mack is CFO and Interim CEO of Gain Therapeutics, Inc.. Currently has a direct ownership of 14,400 shares of GANX, which is worth approximately $24,768. The most recent transaction as insider was on Aug 09, 2024, when has been sold 14,400 shares (Common Stock) at a price of $1.01 per share, resulting in proceeds of $14,544. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
14.4K
0%
3M change
n/a
12M change
Total Value Held
$24,768
GM
Gene Mack
CFO and Interim CEO
Bethesda, MD